Technology
Health
Biotechnology

Aptose Biosciences

$2.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (3.67%) Today
+$0.03 (1.33%) After Hours

Why Robinhood?

You can buy or sell APTO and other stocks, options, ETFs, and crypto commission-free!

About

Aptose Biosciences, Inc. Common Shares, also called Aptose Biosciences, is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Read More Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG'806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Employees
24
Headquarters
Toronto, Ontario
Founded
1986
Market Cap
76.34M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
290.35K
High Today
$2.35
Low Today
$2.19
Open Price
$2.19
Volume
373.62K
52 Week High
$4.55
52 Week Low
$1.57

Collections

Technology
Health
Biotechnology
Medical
Research And Development
Cancer Prevention
2014 IPO
Canada

News

Seeking AlphaMar 13

Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2018 Results - Earnings Call Transcript

Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2018 Earnings Conference Call March 12, 2019 5:00 PM ET Company Participants Susan Pietropaolo - SMP Communications William Rice - Chairman, President, and CEO Gregory Chow - SVP and CFO Conference Call Participants Mathew Bilger - Oppenheimer Gregory Renza - RBC Capital Markets Joe Pantginis - HC Wainwright John Newman - Canaccord Genuity Limited Operator Good afternoon. My name is Dillon and I’ll be your conference operator today. I would like to welcome...

112
Simply Wall StMar 8

Could Aptose Biosciences Inc.’s (TSE:APS) Investor Composition Influence The Stock Price?

Every investor in Aptose Biosciences Inc. (TSE:APS) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to see insiders own a fair bit of smaller companies. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, ‘Don’t tell me what you think, tell me what you have in your portfolio.’ Aptose Biosciences is a smaller company with a market capitalization of CA$89m, ...

410

Earnings

-$0.23
-$0.19
-$0.15
-$0.11
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.14 per share
Actual
-$0.17 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.